These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 33975551)
1. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study. Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551 [TBL] [Abstract][Full Text] [Related]
2. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer. Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180 [TBL] [Abstract][Full Text] [Related]
3. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014. Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212 [TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis. Nelson RA; Guye ML; Luu T; Lai LL Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264 [TBL] [Abstract][Full Text] [Related]
5. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233 [TBL] [Abstract][Full Text] [Related]
6. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
7. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database. Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810 [TBL] [Abstract][Full Text] [Related]
8. Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study. Tan RYC; Ong WS; Lee KH; Park S; Iqbal J; Park YH; Lee JE; Yu JH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Koh J; Han W; Im SA; Tan VKM; Phyu N; Wong FY; Tan PH; Yap YS J Natl Compr Canc Netw; 2024 May; 22(2 D):. PubMed ID: 38744306 [TBL] [Abstract][Full Text] [Related]
9. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified. Cao AY; He M; Huang L; Shao ZM; Di GH World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710 [TBL] [Abstract][Full Text] [Related]
11. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis. Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365 [TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma. Li Y; Zhang N; Zhang H; Yang Q J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384 [TBL] [Abstract][Full Text] [Related]
13. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study. Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840 [TBL] [Abstract][Full Text] [Related]
14. Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women. Tseng HS; Lin C; Chan SE; Chien SY; Kuo SJ; Chen ST; Chang TW; Chen DR World J Surg Oncol; 2013 Jun; 11():139. PubMed ID: 23768133 [TBL] [Abstract][Full Text] [Related]
15. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma. Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559 [TBL] [Abstract][Full Text] [Related]
16. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast. Zhao H Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198 [TBL] [Abstract][Full Text] [Related]
17. Metaplastic breast cancer: clinicopathological features and its prognosis. Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048 [TBL] [Abstract][Full Text] [Related]
18. Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database. McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognosis of mucinous breast carcinoma. Zhang M; Teng XD; Guo XX; Zhao JS; Li ZG J Cancer Res Clin Oncol; 2014 Feb; 140(2):265-9. PubMed ID: 24305754 [TBL] [Abstract][Full Text] [Related]
20. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis. Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]